Premium Only Content

Are New Alzheimer’s Drugs All They Promise To Be?
Researchers question the impact of amyloid immunotherapy on Alzheimer’s, highlighting the small benefits versus significant risks and costs.
Despite regulatory approval by the FDA, other bodies like the EMA express reservations, reflecting broader concerns about these treatments’ real-world efficacy.
Alzheimer’s Immunotherapy Challenges
Cambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impact of Alzheimer’s disease.
Writing in the journal Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the team from Cambridge Public Health argues that substantial challenges including the risk-benefit ratio, limited eligibility, and high cost of the roll-out will limit any benefits of these treatments.
-
LIVE
The Bubba Army
21 hours agoMore Epstein Files Dropped! - Bubba the Love Sponge® Show | 9/09/25
5,501 watching -
LIVE
FyrBorne
18 hours ago🔴Warzone M&K Sniping: How To Harness The Beast (Of Sniping)
145 watching -
7:02
Sugar Spun Run
23 hours ago $0.82 earnedBrownies from Scratch
19.4K4 -
10:07
The Official Steve Harvey
15 hours ago $0.13 earned82 Years of Love, Laughs & Keeping It Real
1.39K -
7:00
DropItLikeItsScott
14 hours ago $0.56 earnedIs This The Best 1911 Pistol Ever Made? Oriskany Arms 1911
2.99K2 -
2:03:01
MG Show
19 hours agoBiden Auto Pen Scandal; President Trump White House Religious Liberty Commission
10.6K12 -
14:18
Actual Justice Warrior
3 days agoBody Camera Video DESTROYS BLM Hoax
9.51K14 -
21:17
itsSeanDaniel
1 day agoCNN Host's Vaccine Lies BACKFIRE in Front of MAGA Doctor
10.2K12 -
1:00:48
Dialogue works
1 day ago $1.51 earnedMark Sleboda: Putin DROPS a Bombshell on Trump… as China & India Shake the World!
18K4 -
8:03
MattMorseTV
17 hours ago $8.10 earnedTrump just GAVE THE ORDER.
56.5K40